The Europe Skin Antiseptic Market would witness market growth of 6.8% CAGR during the forecast period (2023-2029).
Every hospital setting experiences skin antisepsis. In the last few years, the usage of antimicrobial treatments to lessen skin microflora has soared, ranging from simple hand hygiene to antiseptic bathing & pre-surgical care with alcohol/chlorhexidine. While being used to decrease the risk of infection in patients, some products have been blamed for infection outbreaks, sometimes due to the non-sterility of the numerous easily accessible antiseptics.
It is projected that the need for skin antiseptics would be driven by the expanding infection control problem in gastrointestinal endoscopic and endoscope reprocessing. The expansion of the skin antiseptic market is also predicted to be boosted by the rising rates of respiratory infections, urinary tract infections, and endoscopies. Among other categories, the demand for solution-based skin antiseptics is significant. The factors projected to drive demand for the skin antiseptic market include changing consumer tastes, rising awareness of preventive healthcare, and rising healthcare spending.
The number of elderly people in some European nations is rapidly rising. The population of the EU is anticipated to increase from 511 million in 2016 to 520 million in 2070, according to a 2018 Ageing Report published by the EU. However, fewer people will be in the working age group (defined as those between the ages of 15 and 64), dropping from 333 million in 2016 to 292 million in 2070. These factors are all involved in the market expansion in the Europe region. In England, falls and fractures were the most common and serious health issues for older people. This may raise the need for surgeries and thereby lead to the growth of the regional skin antiseptic market.
The Germany market dominated the Europe Skin Antiseptic Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $162.5 million by 2029. The UK market is exhibiting a CAGR of 5.9% during (2023 - 2029). Additionally, The France market would display a CAGR of 7.5% during (2023 - 2029).
Based on Type, the market is segmented into Alcohol, Chlorhexidine, Iodine and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Form, the market is segmented into Solutions, Swab Sticks, Cream and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Skin Antiseptic Market is Projected to reach USD 2.5 Billion by 2029, at a CAGR of 7.4%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHÜLKE & Mayr GmbH, MÖLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
By Type
By Distribution Channel
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 